blog.aids.gov − Conversations from CROI 2015: Dr. Laura Cheever
AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU
Translate
Text SizePrint

Conversations from CROI 2015: Dr. Laura Cheever

Colleagues from HRSA and CDC collaborated on a poster presented at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) Exit Disclaimer last week that demonstrated the effectiveness of the Ryan White HIV/AIDS Program. We had the opportunity to discuss these research findings with Dr. Laura Cheever, HRSA’s Associate Administrator for the HIV/AIDS Bureau, which manages the Ryan White HIV/AIDS Program (RWHAP). She provided us with an overview of the poster presented at the conference of HIV and other infectious disease researchers held in Seattle last week.

croi2015_w280x100

The poster was titled “Impact of the Ryan White HIV/AIDS Program on HIV Treatment Outcomes in the U.S” [PDF 289KB]. It presents analysis of data from CDC’s Medical Monitoring Project from 2009-2012 to assess the association between receiving RWHAP assistance, alone or in combination with other sources of healthcare coverage, and HIV treatment outcomes among HIV-infected adults in medical care. As Dr. Cheever explains in this video interview, the analysis found that uninsured and under-insured persons living with HIV infection who received RWHAP assistance were more likely to be prescribed ART and be virally suppressed than those with many other healthcare payer types.